You have 9 free searches left this month | for more free features.

disseminated tumor cells

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

Blood Markers of Tumor Dissemination in Versus Without

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Blood test
  • Nîmes, France
    CHU de Nîmes
Dec 5, 2022

Breast Cancer Trial in Oslo (Docetaxel)

Completed
  • Breast Cancer
  • Oslo, Norway
    RRHF
Apr 21, 2022

Early Stage Breast Cancer Trial in San Francisco (Denosumab)

Terminated
  • Early Stage Breast Cancer
  • San Francisco, California
    University of California San Francisco
Dec 13, 2019

Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

Completed
  • Stage III Malignant Melanoma of Skin AJCC V6
  • Stage IV Malignant Melanoma of Skin
  • TAPCells vaccine
  • Santiago, RM, Chile
    Faculty of Medicine, University of Chile
Nov 21, 2023

Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
  • Montpellier, France
    CHU Montpellier
Jul 1, 2022

Breast Tumor, Neoplastic Cells, Circulating Trial in Handan (Peripheral blood sampling for circulating tumor cells)

Active, not recruiting
  • Breast Neoplasm
  • Neoplastic Cells, Circulating
  • Peripheral blood sampling for circulating tumor cells
  • Handan, Hebei, China
    Kunwu Yan
Jan 26, 2023

Circulating and Tumor-infiltrating Immune Cells in Malignant

Recruiting
  • Brain Tumor, Primary
  • Brain Tumor - Metastatic
  • Circulating leukocytes immunophenotype
  • Tumor sampling
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Apr 14, 2023

Ethmoid Sinus Tumor, Adenocarcinoma, Circulating Tumor Cell Trial (Liquid biopsy)

Not yet recruiting
  • Ethmoid Sinus Tumor
  • +2 more
  • Liquid biopsy
  • (no location specified)
Oct 18, 2023

Blood, Urine, and Bone Marrow

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Test for circulating tumor cells, DNA alterations
  • Columbia, Missouri
    Harry S Truman Veterans Memorial Hospital
Oct 31, 2022

Multiple Myeloma Cells From miRNAs Released From B Cells, and

Recruiting
  • Multiple Myeloma
    • Aviano, Pordenone, Italy
      Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
    Nov 23, 2023

    Lung Cancer Trial in Toulouse (Blood samples will be collected at two times before the treatment initiation:)

    Not yet recruiting
    • Lung Cancer
    • Blood samples will be collected at two times before the treatment initiation:
    • Toulouse, France
    • +1 more
    Aug 3, 2023

    Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

    Recruiting
    • Oncology
    • moderate Whole Body Hyperthermia (mWBH)
    • Berlin, Germany
      Klinik für Radioonkologie und Strahlentherapie
    Apr 6, 2023

    Circulating Tumor Cells and Neutrophils Count for Colorectal

    Completed
    • Metastatic Colorectal Cancer
      • Nice, France
      • +1 more
      Mar 20, 2023

      Clinical Significance of Circulating Tumour Cells in Resectable

      Completed
      • Non Small Cell Lung Cancer
      • Circulating Tumor Cell
      • Device for CTC/DTC detection
      • Olomouc, Česká Republika, Czechia
        University Hospital Olomouc
      Nov 9, 2022

      Circulating Tumor Cells in Solid Tumors

      Completed
      • Solid Tumor, Adult
      • Observational
      • Chapel Hill, North Carolina
        Radiation Oncology Clinic - UNC Cancer Hospital
      Sep 27, 2022

      Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

      Recruiting
      • Liver Cell Carcinoma
      • +7 more
      • CATCH T cells
      • +2 more
      • Houston, Texas
        Houston Methodist Hospital
      Dec 19, 2022

      Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +4 more
      • (no location specified)
      Oct 23, 2023

      Liquid Biopsy Collection Study

      Completed
      • Chaperonin-Containing TCP-1
      • +3 more
        • Orlando, Florida
          University of Central Florida
        Oct 4, 2023

        Prostate Cancer Trial (prostate cancer diagnosis)

        Not yet recruiting
        • Prostate Cancer
        • prostate cancer diagnosis
        • (no location specified)
        Jul 14, 2023

        Liquid Biospy for Urinary Cancers

        Recruiting
        • Urothelial Carcinoma
        • Genetic analysis on isolated cells
        • Milan, Italy
          Urology Department
        Nov 6, 2023

        Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))

        Completed
        • Melanoma
        • Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Jan 12, 2023

        Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor

        Not yet recruiting
        • Pediatric Brain Tumor
        • +2 more
        • Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
        • Implantation
        • San Francisco, California
          University of California, San Francisco
        May 24, 2023

        Determination of Blood Tumor Cells

        Completed
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • Abnormalities Cell Epithelial
          • Zurich, Switzerland
            University Hospital Zurich
          Jan 9, 2023

          Circulating Tumor Cells From Cancer Patients Undergoing

          Completed
          • Circulating Tumor Cells
          • Blood draw
          • Chapel Hill, North Carolina
            University of North Carolina at Chapel Hill, Department of Radia
          Sep 27, 2022